A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Clinical trial NCT03149003 · COMPLETED
Trial details
- NCT number
- NCT03149003
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-08
- Primary completion
- 2021-08-30
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.